and development of
new antibiotics and
The Netherlands Antibiotic Development Platform
The Netherlands Antibiotic Development Platform (NADP) facilitates the collaboration between public and private organisations, to enhance the development of new antibiotics and alternative therapies for infectious diseases in humans and animals.
NADP will identify relevant research groups, institutes and companies involved in chemical, biological, and/or biomedical antibiotic research to forge collaborations through targeted connections and will organise regular meetings with interested parties.
Stay informed on NADP and subscribe to our Update.
An important objective of NADP is to increase R&D productivity related to new antibiotics and alternatives. To promote the accelerated development of promising 'leads', NADP has developed a financing instrument specifically for this purpose: the NADP Vouchers.
These vouchers can be used in various phases of drug development to gain advice and intensive supervision of research projects from independent consultants or CROs that have specific knowledge and expertise pertinent to the pharmaceutical development process and clinical applications.
NWO has open calls for feasibility studies that are comparable to the NADP vouchers.
After three years being hosted by University Medical Center Utrecht the NADP support office has now moved to the Institute of Biology, Leiden University.
NADP Executive Board member Cornelis Boersma appointed professor of “Sustainable Care and Innovation”
Cornelis Boersma, member of the NADP Executive Board, has been appointed professor of “Sustainable Care and Innovation” at the Open University in the Netherlands. The chair at the Nijmegen School of Management was established by VEROZ, the knowledge center for promoting innovation and entrepreneurship in healthcare.